Beijing SL Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 913.38 million compared to CNY 842.44 million a year ago. Revenue was CNY 913.38 million compared to CNY 842.44 million a year ago. Net income was CNY 435.94 million compared to CNY 303.24 million a year ago. Basic earnings per share from continuing operations was CNY 0.4243 compared to CNY 0.2952 a year ago. Diluted earnings per share from continuing operations was CNY 0.4243 compared to CNY 0.2952 a year ago.